Patentable/Patents/US-9618514
US-9618514

Methods of evaluating patients using E-cadherin and vimentin

PublishedApril 11, 2017
Assigneenot available in USPTO data we have
Inventorsnot available in USPTO data we have
Technical Abstract

Methods for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.

Patent Claims

Legal claims defining the scope of protection. Each claim is shown in both the original legal language and a plain English translation.

Claims not yet imported for this patent.

Claims are being imported from USPTO data. Check back soon!

Classification Codes (CPC)

Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.

Patent Metadata

Filing Date

September 16, 2013

Publication Date

April 11, 2017

Want to explore more patents?

Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.

Citation & reuse

Analysis on this page is generated by Patentable — an AI-powered patent intelligence platform. AI-generated summaries, explanations, FAQs, and analysis may be reused with attribution and a visible link back to the canonical URL below. Patent abstracts and claims are USPTO public domain.

Cite as: Patentable. “Methods of evaluating patients using E-cadherin and vimentin” (US-9618514). https://patentable.app/patents/US-9618514

© 2026 Nomic Interactive Technology LLC. Machine-readable context available at /api/llm-context/US-9618514. See llms.txt for full attribution policy.